Drug intelligence / Profile preview

PrimaCare One

Development stage: Unknown
Lead developer: Ther-Rx
Modality: Small Molecules
Administration: Oral

Overview

PrimaCare One is a prescription prenatal and postnatal multivitamin/mineral supplement designed to support maternal health and fetal development. Marketed by Ther-Rx Corporation, it is formulated as a once-daily purple soft gelatin capsule containing a comprehensive blend of essential vitamins, minerals, and omega-3 fatty acids, including docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA). The supplement provides 1 mg of folic acid to help prevent neural tube defects and iron to support the increased nutritional demands of pregnancy. It is indicated for the treatment or prevention of vitamin and mineral deficiencies before, during, and after pregnancy.

Brand names: PrimaCare One

Targets

FOLR1 (FRα)PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on PrimaCare One.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrimaCare One.

Explore the full profile